Cited by 470Cervical Cancer and HPV ResearchWomen's cancer prevention and managementReproductive tract infections research

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., Matchar, D. B.·2000·American Journal of Epidemiology

DOI 10.1093/oxfordjournals.aje.a010166

Open this paper in CoChat — free account

Abstract

The authors constructed a Markov model as part of a systematic review of cervical cytology conducted at the Duke University Evidence-based Practice Center (Durham, North Carolina) between October 1997 and September 1998. The model incorporated states for human papillomavirus infection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer stages I-IV to simulate the natural history of HPV infection in a cohort of women from ages 15 to 85 years. The age-specific incidence rate of HPV, and regression and progression rates of HPV and squamous intraepithelial lesions, were obtained from the literature. The effects of varying natural history parameters on cervical cancer incidence were evaluated by using sensitivity analysis. The base-case model resulted in a lifetime cervical cancer risk of 3.67% and a lifetime cervical cancer mortality risk of 1.26%, with a peak incidence of 81/100,000 at age 50 years. Age-specific distributions of precursors were similar to reported data. Lifetime risk of cancer was most sensitive to the incidence of HPV and the probability of rapid HPV progression to high-grade lesions (two- to threefold variations in risk). The model approximates the age-specific incidence of cervical cancer and provides a tool for evaluating the natural history of HPV infection and cervical cancer carcinogenesis as well as the effectiveness and cost-effectiveness of primary and secondary prevention strategies.

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.aje.a010166

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
SCHIFFMAN, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,197
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, L. A. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,103
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J. A., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 940
Screening for Cervical Cancer
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 841
Meta-analysis of Pap Test Accuracy
Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 690
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., SCHIFFMAN, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics
Quinn, M. A., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
Moscicki, A., Shiboski, S. C., Broering, J. M., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R. J., Kanowitz, S., Miller, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 562

Show all 49 references

Sorted by citations

Items 101–200 of 467

Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population
Hang, D., Yin, Y., Han, J., Jiang, J., Ma, H., Xie, S., Feng, X., Zhang, K., Hu, Z., Shen, H., et al. (2015) · Virology · doi:10.1016/j.virol.2015.11.016 · Cited by 51
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky, L. J., Sanders, G. D., Kulasingam, S., & Myers, E. R. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.006 · Cited by 51
Self-citation
Health and economic impact associated with a quadrivalent HPV vaccine in Italy
Mennini, F. S., Rossi, P. G., Palazzo, F., & Largeron, N. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.09.031 · Cited by 50
Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia
Deshmukh, A. A., Chiao, E. Y., Das, P., & Cantor, S. B. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.052 · Cited by 50
Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis
Berkhof, J. H., de Bruijne, M. C., Zielinski, G. D., Bulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Verheijen, R. H. M., & Meijer, C. J. L. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21513 · Cited by 50
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
Xia, C., Xu, X., Zhao, X., Hu, S., Qiao, Y., Zhang, Y., Hutubessy, R. C. W., Basu, P. S., Broutet, N. J. N., Jit, M., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01930-9 · Cited by 49
The Health and Economic Impact of Cervical Cancer Screening and Human Papillomavirus Vaccination in Kidney Transplant Recipients
Wong, G., Howard, K., Webster, A. C., Chapman, J. R., & Craig, J. C. (2009) · Transplantation · doi:10.1097/tp.0b013e31819d32eb · Cited by 48
Effectiveness and Efficiency of Opportunistic Cervical Cancer Screening
Adab, P., McGhee, S. M., Yanova, J., Wong, C. M., & Hedley, A. J. (2004) · Medical Care · doi:10.1097/01.mlr.0000128007.04494.29 · Cited by 48
The Effectiveness of a Facebook-Assisted Teaching Method on Knowledge and Attitudes About Cervical Cancer Prevention and HPV Vaccination Intention Among Female Adolescent Students in Taiwan
Lai, C.-Y., Wu, W., Tsai, S., Cheng, S.-F., Lin, K., & Liang, S. (2014) · Health Education & Behavior · doi:10.1177/1090198114558591 · Cited by 46
Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country
Vale, D. B., Silva, M. T., Discacciati, M. G., Polegatto, I., Teixeira, J. C., & Zeferino, L. C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251688 · Cited by 46
Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland
Szucs, T. D., Largeron, N., Dedes, K. J., Rafia, R., & Bénard, S. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x297826 · Cited by 48
Mathematical analysis of a two-sex Human Papillomavirus (HPV) model
Omame, A., Umaña, R. A., Okuonghae, D., & Inyama, S. C. (2018) · International Journal of Biomathematics · doi:10.1142/s1793524518500924 · Cited by 45
The Pittsburgh Cervical Cancer Screening Model: A Risk Assessment Tool
Austin, R. M., Oniśko, A., & Drużdżel, M. J. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.5.744 · Cited by 45
Primary screening for cervical cancer through self sampling
Holanda, F. R., Castelo, A., Veras, T. M. C. W., de Almeida, F. M. L., Lins, M. Z., & das Dôres, G. B. (2006) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2006.07.012 · Cited by 47
Knowledge, attitudes and barriers for human papilloma virus (HPV) vaccines among Malaysian women.
Al‐Dubai, S. A. R., Alshagga, M. A., Al-Naggar, R. A., Al-Jashamy, K. A., Baobaid, M. F., Cp, T., & Sy, A. K. (2010) · PubMed · Cited by 45
Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
Huh, W. K., Williams, E., Huang, J., Bramley, T., & Poulios, N. (2014) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0135-4 · Cited by 44
Human Papillomavirus Testing for Cervical Cancer Screening: Results From a 6-Year Prospective Study in Rural China
Shi, J.-F., Belinson, J. L., Zhao, F., Pretorius, R. G., Li, J., Ma, J.-F., Chen, F., Xiang, W., Pan, Q., Zhang, X., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp188 · Cited by 45
The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis
Felix, J. C., Lacey, M. J., Miller, J. D., Lenhart, G. M., Spitzer, M., & Kulkarni, R. (2016) · Journal of Women s Health · doi:10.1089/jwh.2015.5708 · Cited by 44
The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?
Cox, J. T. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000216315.72572.fb · Cited by 46
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
Largeron, N., Petry, K. U., Jacob, J., Bianic, F., Anger, D., & Uhart, M. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2016.1208087 · Cited by 43
Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
Mo, X., Gai, R. T., Wang, L., Liu, X., Wu, B. Y., Luo, H., Nagata, C., Mori, R., & Nakayama, T. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2592-5 · Cited by 43
Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa
Vijayaraghavan, A., Efrusy, M. B., Lindeque, G., Dreyer, G., & Santas, C. C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.030 · Cited by 43
Costs and Effectiveness of Alternative Strategies for Cervical Cancer Screening in Military Beneficiaries
Maxwell, G. L., Carlson, J. W., Ochoa, M., Krivak, T., Rose, G. S., & Myers, E. R. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02195-6 · Cited by 43
Self-citation
Human papilloma virus (HPV) genotypes prevalence in a region of South Italy (Apulia).
Coscia, M. F., Monno, R., Ballini, A., Mirgaldi, R., Dipalma, G., Pettini, F., Cristallo, V., Inchingolo, F., Foti, C., & Vito, D. D. (2015) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_15_03_14 · Cited by 42
Updated Guidelines for Papanicolaou Tests, Colposcopy, and Human Papillomavirus Testing in Adolescents
Widdice, L. E., & Moscicki, A. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.04.007 · Cited by 44
Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands
Berkhof, J. H., de Bruijne, M. C., Zielinski, G. D., & Meijer, C. J. L. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.20846 · Cited by 42
Chapter 15: Public Health Policy and Cost-Effectiveness Analysis
Goldie, S. J. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003471 · Cited by 42
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination
Debicki, D., Ferko, N. C., Demarteau, N., Gallivan, S., Bauch, C. T., Anonychuk, A. M., Mantovani, L. G., Capri, S., Chou, C.-Y., Standaert, B. A., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.040 · Cited by 44
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study
Haeussler, K., Marcellusi, A., Mennini, F. S., Favato, G., Picardo, M., Garganese, G., Bononi, M., Costa, S., Scambia, G., Zweifel, P. S., et al. (2015) · Value in Health · doi:10.1016/j.jval.2015.08.010 · Cited by 42
Missed Opportunities in Preventing Hospital Readmissions: Redesigning Post‐Discharge Checkup Policies
Liu, X., Hu, M., Helm, J. E., Lavieri, M. S., & Skolarus, T. A. (2018) · Production and Operations Management · doi:10.1111/poms.12858 · Cited by 41
Psychological distress in cervical cancer screening: results from a German online survey
Jentschke, M., Lehmann, R., Drews, N., Hansel, A., Schmitz, M., & Hillemanns, P. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05661-9 · Cited by 41
Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests
Kulasingam, S., Myers, E. R., Lawson, H. W., McConnell, K. J., Kerlikowske, K. M., Melnikow, J. A., Washington, A. E., & Sawaya, G. F. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000196500.50044.ce · Cited by 41
Self-citation
Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India
Gupta, N. M., Chauhan, A. S., Prinja, S., & Pandey, A. K. (2021) · JCO Global Oncology · doi:10.1200/go.20.00654 · Cited by 41
The impact of an imperfect vaccine and pap cytologyscreening on the transmission of human papillomavirus and occurrenceof associated cervical dysplasia and cancer
Malik, T. M., Reimer, J. R., Gumel, A. B., Elbasha, E. H., & Mahmud, S. M. (2013) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2013.10.1173 · Cited by 40
Awareness of cervical cancer among women in Malaysia.
Lee, M.-S., Rosman, A. N., Khan, A. L., Haris, N. M., Mustapha, N. A. S., Husaini, N. S. M., & Zahari, N. F. (2018) · Europe PMC (PubMed Central) · Cited by 40
Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data
Jit, M., Gay, N. J., Soldan, K., Choi, Y. H., & Edmunds, W. J. (2009) · Medical Decision Making · doi:10.1177/0272989x09336140 · Cited by 40
Human papillomavirus vaccination in survivors of childhood cancer
Klosky, J. L., Gamble, H. L., Spunt, S. L., Randolph, M. E., Green, D. M., & Hudson, M. M. (2009) · Cancer · doi:10.1002/cncr.24669 · Cited by 40
Cost-effectiveness of primary HPV screening for cervical cancer in Germany—a decision analysis
Sroczynski, G., Schnell-Inderst, P., Mühlberger, N., Lang, K., Aidelsburger, P., Wasem, J., Mittendorf, T., Engel, J., Hillemanns, P., Petry, K. U., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.006 · Cited by 40
Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S.
Kulasingam, S. L., Pagliusi, S., & Myers, E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.09.035 · Cited by 39
Self-citation
Effects on Vaginal Microbiota Restoration and Cervical Epithelialization in Positive HPV Patients Undergoing Vaginal Treatment with Carboxy‐Methyl‐Beta‐Glucan
Lavitola, G., Corte, L. D., Rosa, N. D., Nappi, C., & Bifulco, G. (2020) · BioMed Research International · doi:10.1155/2020/5476389 · Cited by 39
Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004.
Jain, N., Irwin, K. L., Montaño, D. E., Kasprzyk, D., Carlin, L., Freeman, C., Barnes, R., Christian, J., & Wolters, C. L. (2006) · PubMed · Cited by 39
Natural History of Anal Dysplasia in an HIV-Infected Clinical Care Cohort: Estimates Using Multi-State Markov Modeling
Mathews, W. C., Agmas, W., Cachay, E. R., Cosman, B. C., & Jackson, C. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104116 · Cited by 38
Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis
Pańczyszyn, A., Boniewska‐Bernacka, E., & Głąb, G. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0336-x · Cited by 38
Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Québec, Canada
Vijayaraghavan, A., Efrusy, M. B., Mayrand, M., Santas, C. C., & Goggin, P. (2010) · Canadian Journal of Public Health · doi:10.1007/bf03404377 · Cited by 37
Concurrency, Sex Partner Risk, and High-Risk Human Papillomavirus Infection Among African American, Asian, and Hispanic Women
Javanbakht, M., Gorbach, P. M., Amani, B., Walker, S., Cranston, R., Datta, S., & Kerndt, P. R. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181bcd3e7 · Cited by 37
Knowledge and Beliefs About Abnormal Pap Test Results and HPV Among Women with High-Risk HPV: Results from In-Depth Interviews
Sharpe, P. A., Brandt, H. M., & McCree, D. H. (2006) · Women & Health · doi:10.1300/j013v42n02_07 · Cited by 37
A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer
Campos, N. G., Demarco, M., Bruni, L., Desai, K. T., Gage, J. C., Adebamowo, S. N., de Sanjosé, S., Kim, J. J., & SCHIFFMAN, M. H. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106438 · Cited by 35
Cytomorphologic analysis and histological correlation of high-grade squamous intraepithelial lesions in postmenopausal women
Saad, R. S., Kanbour‐Shakir, A., Lu, E., Modery, J., & KANBOUR, A. I. (2006) · Diagnostic Cytopathology · doi:10.1002/dc.20475 · Cited by 36
Efficacy of Vaccination against HPV Infections to Prevent Cervical Cancer in France: Present Assessment and Pathways to Improve Vaccination Policies
Ribassin-Majed, L., Lounès, R., & Clémençon, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032251 · Cited by 35
A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines
Guerrero, A. M., Genuino, A. J., Santillan, M., Praditsitthikorn, N., Chantarastapornchit, V., Teerawattananon, Y., Alejandria, M., & Toral, J. A. B. (2015) · BMC Public Health · doi:10.1186/s12889-015-2046-1 · Cited by 37
CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme
Nygård, J. F., Sauer, T., Nygård, M., Skare, G. B., & Thoresen, S. (2004) · Journal of Medical Screening · doi:10.1258/096914104774061047 · Cited by 35
Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies
Yahia, M.-B. B. H., Jouin-Bortolotti, A., & Dervaux, B. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0308-4 · Cited by 36
Vulvar and Vaginal HPV Disease
Nelson, E. L., & Stockdale, C. K. (2013) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.03.003 · Cited by 34
Interleukin-10 Gene (IL10) Polymorphisms and Human Papillomavirus Clearance among Immunosuppressed Adolescents
Shrestha, S., Wang, C., Aïssani, B., Wilson, C. M., Tang, J., & Kaslow, R. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0881 · Cited by 34
Inference of Type-Specific HPV Transmissibility, Progression and Clearance Rates: A Mathematical Modelling Approach
Johnson, H. C., Elfström, K. M., & Edmunds, W. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049614 · Cited by 34
Characteristics of vaginal microbiota in various cervical intraepithelial neoplasia: a cross-sectional study
Liu, Y., Wang, S., Liu, J., Su, M., Diao, X., Liang, X., Zhang, J., Wang, Q., & Zhan, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04676-5 · Cited by 33
Risk Factors for Non-initiation of the Human Papillomavirus Vaccine among Adolescent Survivors of Childhood Cancer
Klosky, J. L., Russell, K. M. W., Canavera, K. E., Gammel, H. L., Hodges, J., Foster, R. H., Parra, G. R., Simmons, J. L., Green, D. M., & Hudson, M. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0127 · Cited by 34
Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan
Liu, P.-H., Hu, F., Lee, P., Chow, S., Huang, C.-W., & Wang, J. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-11 · Cited by 34
Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program
Nygård, J. F., Nygård, M., Skare, G. B., & Thoresen, S. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-6295-z · Cited by 33
Epidemiology, Clinical Manifestations, and Recent Advances in Vaccination against Human Papillomavirus
Broomall, E. M., Reynolds, S. M., & Jacobson, R. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.03.2129 · Cited by 32
Cost-Effectiveness Evaluation of a Quadrivalent Human Papillomavirus Vaccine in Belgium
Annemans, L., Rémy, V., Oyee, J., & Largeron, N. (2009) · PharmacoEconomics · doi:10.2165/00019053-200927030-00006 · Cited by 35
Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results
Venturoli, S., Cricca, M., Bonvicini, F., Giosa, F., Pulvirenti, F. R., Galli, C., Musiani, M., & Zerbini, M. (2002) · Journal of Clinical Virology · doi:10.1016/s1386-6532(02)00007-0 · Cited by 32
Correlates of intent to be vaccinated against human papillomavirus: an exploratory study of college-aged women
Crosby, R. A., Schoenberg, N. E., Hopenhayn, C., Moore, G., & Melhan, W. (2007) · Sexual Health · doi:10.1071/sh06046 · Cited by 32
HPV-16 infection and cervical cancer: Modeling the influence of duration of infection and precancerous lesions
Baussano, I., Ronco, G., Segnan, N., French, K., Vineis, P., & Garnett, G. P. (2010) · Epidemics · doi:10.1016/j.epidem.2010.02.002 · Cited by 32
Sexually Transmitted Infections and Pelvic Inflammatory Disease in Women
Trigg, B. G., Kerndt, P. R., & Aynalem, G. (2008) · Medical Clinics of North America · doi:10.1016/j.mcna.2008.04.011 · Cited by 31
CIN 2/3 and Cervical Cancer After an ASCUS Pap Smear
Nygård, J. F., Sauer, T., Skjeldestad, F. E., Baadstr, G., Skare, N. I. L., & Thoresen, S. (2003) · Acta Cytologica · doi:10.1159/000326673 · Cited by 31
Impact of the National Breast and Cervical Cancer Early Detection Program on Cervical Cancer Mortality Among Uninsured Low-Income Women in the U.S., 1991–2007
Ekwueme, D. U., Uzunangelov, V., Hoerger, T. J., Miller, J. W., Saraiya, M., Benard, V. B., Hall, I. J., Royalty, J., Li, C., & Myers, E. R. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.05.016 · Cited by 29
Self-citation
Evaluation of the Acceptability and Feasibility of a Computer-Tailored Intervention to Increase Human Papillomavirus Vaccination Among Young Adult Women
Paiva, A. L., Lipschitz, J. M., Fernandez, A. C., Redding, C. A., & Prochaska, J. O. (2013) · Journal of American College Health · doi:10.1080/07448481.2013.843534 · Cited by 33
Cost-effectiveness of human papillomavirus vaccination in Belgium: Do not forget about cervical cancer screening
Thiry, N., Laet, C. E. D. H. D., Hulstaert, F., Neyt, M., Huybrechts, M., & Cleemput, I. (2009) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309090217 · Cited by 29
Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland
Vassilakos, P., Poncet, A., Catarino, R., Viviano, M., Petignat, P., & Combescure, C. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.01.021 · Cited by 29
Projected cost‐effectiveness of repeat high‐risk human papillomavirus testing using self‐collected vaginal samples in the Swedish cervical cancer screening program
Östensson, E., Hellström, A., Hellman, K., Gustavsson, I. M., Gyllensten, U. B., Wilander, E., Zethraeus, N., & Andersson, S. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12143 · Cited by 30
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis
Kulasingam, S., Rajan, R., Pierre, Y. S., Atwood, C. V., Myers, E. R., & Franco, E. L. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-69 · Cited by 29
Self-citation
Health economics and cervical cancer prevention: a global perspective
Goldie, S. J. (2002) · Virus Research · doi:10.1016/s0168-1702(02)00199-5 · Cited by 29
Operations Research Models for Cancer Screening
Alagöz, O., Ayer, T., & Erenay, F. S. (2011) · Wiley eBooks · doi:10.1002/9780470400531.eorms0597 · Cited by 29
The Cost-Effectiveness of Screening Programs Using Single and Multiple Birth Cohort Simulations: A Comparison Using a Model of Cervical Cancer
Dewilde, S., & Anderson, R. (2004) · Medical Decision Making · doi:10.1177/0272989x04268953 · Cited by 29
Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks
Vahdat, V., Alagöz, O., Chen, J. V., Saoud, L., Borah, B. J., & Limburg, P. J. (2023) · Medical Decision Making · doi:10.1177/0272989x231184175 · Cited by 28
Human Papillomavirus Vaccination
Gattoc, L., Nair, N., & Ault, K. A. (2013) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.03.007 · Cited by 30
Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model
Chesson, H. W., Meites, E., Ekwueme, D. U., Saraiya, M., & Markowitz, L. E. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.019 · Cited by 30
Human papillomavirus infection increases the risk of breast carcinoma: a large-scale systemic review and meta-analysis of case-control studies
Ren, C., Zeng, K., Wu, C., Mu, L., Huang, J., & Wang, M. (2019) · Gland Surgery · doi:10.21037/gs.2019.09.04 · Cited by 27
Association between Vaginal Micro-environment Disorder and Cervical Intraepithelial Neoplasia in a Community Based Population in China
Li, L., Ding, L., Gao, T., Lyu, Y., Wang, M., Song, L., Li, X., Gao, W. X., Han, Y., Jia, H., et al. (2019) · Journal of Cancer · doi:10.7150/jca.35022 · Cited by 27
A FRACTAL FRACTIONAL MODEL FOR CERVICAL CANCER DUE TO HUMAN PAPILLOMAVIRUS INFECTION
Akgül, A., Ahmed, N., Raza, A., Iqbal, Z., Rafiq, M., Rehman, M. A., & Bǎleanu, D. (2021) · Fractals · doi:10.1142/s0218348x21400156 · Cited by 27
Identifying False Human Papillomavirus (HPV) Vaccine Information and Corresponding Risk Perceptions From Twitter: Advanced Predictive Models
Tomaszewski, T., Morales, A., Lourentzou, I., Caskey, R. N., Liu, B., Schwartz, A., & Chin, J. (2021) · Journal of Medical Internet Research · doi:10.2196/30451 · Cited by 29
Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS, LuViva Advanced Cervical Scan and Niris Imaging System: a systematic review and economic evaluation
Wade, R., Spackman, E., Corbett, M. S., Walker, S., Light, K., Naik, R., Sculpher, M., & Eastwood, A. J. (2013) · Health Technology Assessment · doi:10.3310/hta17080 · Cited by 27
Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium
Demarteau, N., Kriekinge, G. V., & Simon, P. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.008 · Cited by 27
Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer
Klosky, J. L., Favaro, B. E., Peck, K. R., Simmons, J. L., Russell, K. M. W., Green, D. M., & Hudson, M. M. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0495-2 · Cited by 27
Histologic findings from the cervix among older women with abnormal cervical cytology
Massad, L. S., Behbakht, K., Collins, Y. C., & Cejtin, H. E. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00135-x · Cited by 26
Reproductive health care after transplantation
Krajewski, C. M., & Sucato, G. S. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.09.002 · Cited by 25
Stability analysis and optimal control of HPV infection model with early-stage cervical cancer
Allali, K. (2020) · Biosystems · doi:10.1016/j.biosystems.2020.104321 · Cited by 25
The Acceptability of HPV Vaccination Among Women Attending the University of Saskatchewan Student Health Services
Giede, C. K., McFadden, L. L., Komonoski, P., Agrawal, A., Stauffer, A., & Pierson, R. A. (2010) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34572-8 · Cited by 26
Surveillance After Treatment for Cervical Intraepithelial Neoplasia
Melnikow, J. A., Kulasingam, S., Slee, C. A., Helms, L. J., Kuppermann, M., Birch, S., McGahan, C. E., Coldman, A. J., Chan, B. K. S., & Sawaya, G. F. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181f88e72 · Cited by 25
Cervical cancer screening among HIV‐infected women: An economic evaluation in a middle‐income country
Vanni, T., Luz, P. M., Grinsztejn, B. G. J., Veloso, V. G., Foss, A. M., Mesa‐Frias, M., & Legood, R. (2011) · International Journal of Cancer · doi:10.1002/ijc.26472 · Cited by 25
Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark
Amdisen, L., Kristensen, M. L., Rytter, D., Mølbak, K., & Valentiner‐Branth, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.006 · Cited by 25
Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening
Vijayaraghavan, A., Efrusy, M. B., Goodman, K. A., Santas, C. C., & Huh, W. K. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.07.004 · Cited by 25
Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
Vink, M. A., Bogaards, J. A., Meijer, C. J. L. M., & Berkhof, J. H. (2014) · International Journal of Cancer · doi:10.1002/ijc.29381 · Cited by 24
Economic Evaluation Studies
Udeh, B. L. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.03.008 · Cited by 24
Protecting the Next Generation: What Is the Role of the Duration of Human Papillomavirus Vaccine–Related Immunity?
Günther, O. P., Ogilvie, G. S., Naus, M., Young, E., Patrick, D. M., Dobson, S., Duval, B., Noël, P., Marra, F., Miller, D. M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/588140 · Cited by 25
Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer
Nahvijou, A., Daroudi, R., Tahmasebi, M., Hashemi, F. A., Hemami‬, M. R., Sari, A. A., Marenani, A. B., & Zendehdel, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156705 · Cited by 24
Organised screening for cervical cancer in France: a cost-effectiveness assessment
Barré, S., Massetti, M., Leleu, H., & BELS, F. D. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014626 · Cited by 24
Diagnosing human papillomaviruses: recent advances
Jenkins, D. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200102000-00010 · Cited by 24
Validation of Decisional Balance and Self-Efficacy Measures for HPV Vaccination in College Women
Lipschitz, J. M., Fernandez, A. C., Larson, H. E., Blaney, C. L., Meier, K. S., Redding, C. A., Prochaska, J. O., & Paiva, A. L. (2013) · American Journal of Health Promotion · doi:10.4278/ajhp.110606-quan-240 · Cited by 24

Authors: Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B.
Affiliations: Duke University (US)
Corresponding author: Myers, E. R.
ORCID: Myers, E. R.
McCrory, D. C.
Nanda, K.
Bastian, L.
Matchar, D. B.
Venue: American Journal of Epidemiology
Publisher: Oxford University Press (OUP)
Published: 2000-06-15
Volume: 151
Issue: 12
Pages: 1158-1171
ISSN: 0002-9262 (ISSN-L)
1476-6256
DOI: 10.1093/oxfordjournals.aje.a010166
OpenAlex: W2113839478
Cited by: 470
References: 49
Citations by year: 2026: 4 · 2025: 16 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 20 · 2016: 12 · 2015: 22 · 2014: 24 · 2013: 32 · 2012: 19
FWCI: 8.82
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Epidemiology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (290-97-0014)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords: HPV infection, cervical carcinogenesis, natural history of HPV infection, squamous intraepithelial lesions, cervical cancer incidence, cervical cancer mortality, lifetime cancer risk, Markov model, cervical cancer prevention, sensitivity analysis
MeSH terms: Adolescent, Adult, Aged, Antiviral Agents, Cell Transformation, Neoplastic, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Humans, Markov Chains, Middle Aged, Models, Theoretical, Tumor Virus Infections, Incidence, Risk Assessment, Papillomaviridae, Papillomavirus Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks